Skip to main content
Log in

18F-fluoromisonidazole (FMISO) PET may have the potential to detect cardiac sarcoidosis

  • Images That Teach
  • Published:
Journal of Nuclear Cardiology Aims and scope

Abstract

18F-fluoromisonidazole (FMISO) is a positron emission tomography (PET) tracer that accumulates in hypoxic tissues. We here present a case of suspected cardiac sarcoidosis which was detected with increased FMISO uptake.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Iannuzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. N Engl J Med 2007;357:2153-65.

    Article  CAS  PubMed  Google Scholar 

  2. Birnie DH, Sauer WH, Bogun F, Cooper JM, Culver DA, Duvernoy CS, et al. HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm 2014;11:1305-23.

    Article  PubMed  Google Scholar 

  3. Manabe O, Ohira H, Yoshinaga K, Sato T, Klaipetch A, Oyama-Manabe N, et al. Elevated (18)F-fluorodeoxyglucose uptake in the interventricular septum is associated with atrioventricular block in patients with suspected cardiac involvement sarcoidosis. Eur J Nucl Med Mol Imaging 2013;40:1558-66.

    Article  CAS  PubMed  Google Scholar 

  4. Manabe O, Yoshinaga K, Ohira H, Masuda A, Sato T, Tsujino I, et al. The effects of 18-h fasting with low-carbohydrate diet preparation on suppressed physiological myocardial (18)F-fluorodeoxyglucose (FDG) uptake and possible minimal effects of unfractionated heparin use in patients with suspected cardiac involvement sarcoidosis. J Nucl Cardiol 2016;23:244-52.

    Article  PubMed  Google Scholar 

  5. Toyonaga T, Hirata K, Yamaguchi S, Hatanaka KC, Yuzawa S, Manabe O, et al. 18F-fluoromisonidazole positron emission tomography can predict pathological necrosis of brain tumors. Eur J Nucl Med Mol Imaging 2016.

  6. Shelton ME, Dence CS, Hwang DR, Herrero P, Welch MJ, Bergmann SR. In vivo delineation of myocardial hypoxia during coronary occlusion using fluorine-18 fluoromisonidazole and positron emission tomography: A potential approach for identification of jeopardized myocardium. J Am Coll Cardiol 1990;16:477-85.

    Article  CAS  PubMed  Google Scholar 

  7. Piotrowski WJ, Kiszałkiewicz J, Pastuszak-Lewandoska D, et al. Expression of HIF-1A/VEGF/ING-4 axis in pulmonary sarcoidosis. Adv Exp Med Biol 2015;866:61-9.

    Article  CAS  PubMed  Google Scholar 

  8. Kawai N, Lin W, Cao WD, Ogawa D, Miyake K, Haba R, et al. Correlation between 18F-fluoromisonidazole PET and expression of HIF-1α and VEGF in newly diagnosed and recurrent malignant gliomas. Eur J Nucl Med Mol Imaging 2014;41:1870-8.

    Article  CAS  PubMed  Google Scholar 

Download references

Disclosure

The authors have indicated that they have no financial conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Osamu Manabe MD, PhD.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Manabe, O., Hirata, K., Shozo, O. et al. 18F-fluoromisonidazole (FMISO) PET may have the potential to detect cardiac sarcoidosis. J. Nucl. Cardiol. 24, 329–331 (2017). https://doi.org/10.1007/s12350-016-0495-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12350-016-0495-2

Keywords

Navigation